Back to Menu
1. Surgical treatment
Surgical resection is the only potentially curative approach. The operative procedure is selected based on tumor location, with the goal of achieving an R0 resection.
2. Chemotherapy
Chemotherapy is a central component. Regimens such as FOLFIRINOX are commonly used and may be applied as neoadjuvant, adjuvant, or palliative therapy depending on clinical context.
3. Radiotherapy
Used in neoadjuvant, adjuvant, or palliative settings. Precision techniques can improve local control while sparing normal tissues.
4. Targeted therapy
Targeted agents are selected for specific actionable genomic alterations and require genetic testing to identify eligible patients, aiming to block oncogenic signaling pathways.
5. Immunotherapy
Immune checkpoint inhibitors activate antitumor immunity and are often combined with other modalities to enhance efficacy.
6. Minimally invasive surgery
Laparoscopic and robot-assisted approaches reduce surgical trauma and accelerate recovery, but require strict patient selection and experienced surgeons.
7. Interventional therapy
Arterial infusion chemotherapy and radioactive seed implantation may be used for locally advanced disease to control lesions and alleviate symptoms.
8. Supportive care
Nutritional support, pain control, and pancreatic enzyme replacement are provided throughout treatment to improve tolerance and quality of life.
9. Comprehensive multimodal therapy
An individualized plan integrating multiple modalities is developed, and MDT collaboration ensures scientifically grounded, comprehensive care to maximize benefit.
10. Palliative care
In advanced disease, focus is placed on symptom relief (e.g., pain and jaundice), including interventional measures such as stent placement.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that pancreatic cancer is highly aggressive, complex to treat, and life-threatening. Early diagnosis and standardized treatment are key to improving cure rates. MDT-based collaboration and emerging therapies such as targeted and immunotherapy continue to improve outcomes. The public should increase awareness, undergo regular health examinations, maintain healthy lifestyle practices, and seek prompt medical evaluation when symptoms occur.
1. Surgical treatment
Surgical resection is the only potentially curative approach. The operative procedure is selected based on tumor location, with the goal of achieving an R0 resection.
2. Chemotherapy
Chemotherapy is a central component. Regimens such as FOLFIRINOX are commonly used and may be applied as neoadjuvant, adjuvant, or palliative therapy depending on clinical context.
3. Radiotherapy
Used in neoadjuvant, adjuvant, or palliative settings. Precision techniques can improve local control while sparing normal tissues.
4. Targeted therapy
Targeted agents are selected for specific actionable genomic alterations and require genetic testing to identify eligible patients, aiming to block oncogenic signaling pathways.
5. Immunotherapy
Immune checkpoint inhibitors activate antitumor immunity and are often combined with other modalities to enhance efficacy.
6. Minimally invasive surgery
Laparoscopic and robot-assisted approaches reduce surgical trauma and accelerate recovery, but require strict patient selection and experienced surgeons.
7. Interventional therapy
Arterial infusion chemotherapy and radioactive seed implantation may be used for locally advanced disease to control lesions and alleviate symptoms.
8. Supportive care
Nutritional support, pain control, and pancreatic enzyme replacement are provided throughout treatment to improve tolerance and quality of life.
9. Comprehensive multimodal therapy
An individualized plan integrating multiple modalities is developed, and MDT collaboration ensures scientifically grounded, comprehensive care to maximize benefit.
10. Palliative care
In advanced disease, focus is placed on symptom relief (e.g., pain and jaundice), including interventional measures such as stent placement.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that pancreatic cancer is highly aggressive, complex to treat, and life-threatening. Early diagnosis and standardized treatment are key to improving cure rates. MDT-based collaboration and emerging therapies such as targeted and immunotherapy continue to improve outcomes. The public should increase awareness, undergo regular health examinations, maintain healthy lifestyle practices, and seek prompt medical evaluation when symptoms occur.